GSROX | VEXPX | GSROX / VEXPX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 57 years | - |
Gain YTD | 18.360 | 10.554 | 174% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 129M | 22.6B | 1% |
Annual Yield % from dividends | 0.00 | 0.48 | - |
Returns for 1 year | 33.53 | 24.36 | 138% |
Returns for 3 years | -67.66 | -15.69 | 431% |
Returns for 5 years | -58.32 | 20.26 | -288% |
Returns for 10 years | -52.62 | 20.68 | -254% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FSTA | 50.84 | 0.17 | +0.34% |
Fidelity MSCI Consumer Staples ETF | |||
IGBH | 24.23 | 0.02 | +0.10% |
iShares Interest Rate Hdg L/T Corp BdETF | |||
MMCA | 21.79 | 0.01 | +0.05% |
NYLI MacKay California Muni Intmdt ETF | |||
IEMG | 54.90 | -0.14 | -0.25% |
iShares Core MSCI Emerging Markets ETF | |||
PJP | 88.07 | -0.46 | -0.52% |
Invesco Pharmaceuticals ETF |